1. Li X, Breteler MM, de Bruyne MC, et al. Vascular determinants of epilepsy: the Rotterdam Study. Epilepsia 1997;38:1216.

2. Komrad MS, Coffey CE, Coffey KS, et al. Myocardial infarction and stroke. Neurology 1984;34:1403.

3. Weinrich DJ, Burke JF, Pauletto FJ. Left ventricular thrombi complicating acute myocardial infarction. Long term follow up with serial echocardiography. Ann Intern Med 1984;100:789–794.

4. Caramelli P, Mutarelli EG, Caramelli B, et al. Neurological complications after thrombolytic treatment for acute myocardial infarction: emphasis on unprecedented manifestations. Acta Neurol Scand 1999;85:331–333.

5. Hesdorffer DC, Hauser WA, Annegers JF, Rocca WA. Severe uncontrolled hypertension and adult-onset seizures: a case-control study in Rochester, Minnesota. Epilepsia 1996;37:736–741.

6. Russell JW, Biller J, Hajduczok ZD, et al. Ischemic cerebrovascular complications and risk factors in idiopathic subaortic stenosis. Stroke 1991;22:1143.

7. Chesebro JH, Adams PC, Fuster V. Antithrombotic therapy in patients with valvular heart disease and prosthetic heart valves. J Am Coll Cardiol 1986;8:41B.

8. Wolf PA, Dawber TR, Thomas HE Jr, et al. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology 1978;28:973.

9. Neilson GH, Galea EG, Hossack KF. Thromboembolic complications of mitral valve disease. Aust N Z J Med 1978;8:372.

10. Boughner DR, Barnett NJ. The enigma of risk of stroke in mitral valve prolapse. Stroke 1985;16:175.

11. Barnett HJ, Boughner DR, Taylor DW, et al. Further evidence relating mitral-valve prolapse to cerebral ischemic events. N Engl J Med 1980;302:139.

12. Benjamin EJ, Plehn JF, D’Agostino RB, et al. Mitral annular calcification and the risk of stroke in an elderly cohort. N Engl J Med 1992;327:374–379.

13. McKay RG. The Mansfield Scientific Aortic Valvuloplasty Registry: overview of acute hemodynamic results and procedural complications. J Am Coll Cardiol 1991;17:485.

14. Ryan CA, Robertson M, Coe JY. Seizures due to lidocaine toxicity in a child during cardiac catheterization. Pediatr Cardiol 1993;14:116–118.

15. Salgado AV, Furlan AJ, Keys TF, et al. Neurologic complications of endocarditis: a 12-year experience. Neurology 1989;39:173.

16. Harrison MJ, Hampton JR. Neurological presentation of bacterial endocarditis. BMJ 1967;2:148.

17. Berthrong M, Sabiston DC. Cerebral lesions in congenital heart disease Bull Johns Hopkins Hosp 1951;89:384.

18. John K, Bachman DS, Cooper RF, et al. Electroencephalographic abnormalities in children with congenital heart disease. Arch Neurol 1985;42:794–796.

19. Miller G, Eggli KD, Contant C, et al. Postoperative neurologic complications after open heart surgery on young infants. Arch Pediatr Adolesc Med 1995;149:764–768.

20. Helmers SL, Wypij D, Constantinou JE, et al. Perioperative seizures in infants undergoing repair of complex congenital cardiac defects. Electroencephalogr Clin Neurophysiol 1997;102:27–36.

21. Belkin RN, Pollack BD, Ruggiero ML, et al. Comparison of transesophageal and transthoracic echocardiography with contrast and color flow Doppler in the detection of patent foramen ovale. Am Heart J 1994;128:520–525.

22. Fischbein CA, Rosenthal A, Fischer EG, et al. Risk factors of brain abscess in patients with congenital heart disease Am J Cardiol 1974;34:97.

23. Stafstrom CE, Patxot OF, Gilmore HE, Wisniewski KE. Seizures in children with Down syndrome: etiology, characteristics, and outcome. Dev Med Child Neurol 1991;33:191–200.

24. Moorman JR, Crain B, Osborne D. Kallman’s syndrome with associated cardiovascular and intracranial anomalies. Am J Med 1984;77:369.

25. Quek SC, Yip W, Quek ST, et al: Cardiac manifestations in tuberous sclerosis: a 10-year review. J Paediatr Child Health 1998;34:282–287.

26. Jones M. Anomalies of the brain and congenital heart disease: a study of 52 necropsy cases. Pediatr Pathol 1991;11:721.

27. Shearer WT, Rutman JY, Weinberg WA, et al. Coarctation of the aorta and cerebrovascular accident: a proposal for early corrective surgery. J Pediatr 1970;77:1004.

28. Morley J, Marinchak R, Rials SJ, Kowey P. Atrial fibrillation, anticoagulation, and stroke. Am J Cardiol 1996;77:38A–44A.

29. Reith J, Jorgensen HS, Nakayama H, et al. Seizures in acute stroke: predictors and prognostic significance. The Copenhagen Stroke Study. Stroke 1997;28:1585-1589.

30. Albers GW, Dalen JE, Laupacis A, Manning WJ, Petersen P, Singer DE.. Anti-thrombotic therapy in atrial fibrillation. Chest 2001 Jan; 119[1 Suppl]:194S-206S

31. Wang Q, Chen Q, Li H, Towbin JA. Molecular genetics of long QT syndrome from genes to patients. Curr Opin Cardiol 1997;12:310–320.

32. Chiang CE, Roden DM. The long QT syndromes: genetic basis and clinical implications. J Am Coll Cardiol 2000;36:1–12.

33. Gospe SM, Choy M. Hereditary long Q-T syndrome presenting as epilepsy: electroencephalography laboratory diagnosis. Ann Neurol 1989;25:514–516.

34. Devinsky O, Pacia S, Tatambhotla G. Bradycardia and asystole induced by partial seizures: a case report and literature review. Neurology 1997;48:1712–1714.

35. Reeves A, Nollet KE, Lass DW, et al. The ictal bradycardia syndrome. Epilepsia 1996;37:983–987.

36. Blumhardt LD, Smith PE, Owen L. Electrocardiographic accompaniments of temporal lobe epileptic seizures. Lancet 1986;1:1051.

37. Ossentjuk E, Elink Sterk CJ, Storm van Leeuwen W. Flicker-induced cardiac arrest in a patient with epilepsy. Electroencephalogr Clin Neurophysiol 1966;20:257.

38. Erickson TC. Cardiac activity during epileptic seizures. Arch Neurol Psychiatry 1939;41:511.

39. Boggs JG, Painter JA, DeLorenzo RJ. Analysis of electrocardiographic changes in status epilepticus. Epilepsy Res 1993;14:87–94.

40. Keilson MJ, Hauser A, Magrill JP, et al. ECG abnormalities in patients with epilepsy. Neurology 1987;37:1624.

41. Boggs JG, Marmarou A, Agnew JP, et al. Hemodynamic monitoring at the time of death in status epilepticus. Epilepsy Res 1998;31:199–209.

42. Ficker DM. Sudden unexplained death and injury in epilepsy. Epilepsia 2000;41[Suppl 2]:S7–S12.

43. Walczak TS, Hauser WA, Leppik IE, et al. Incidence and risk factors for sudden unexpected death in epilepsy: a prospective cohort study. Neurology 1998;50[Suppl 4]:443–444.

44. Lathers CM, Schraeder PL, Boggs JG. Sudden Unexpected Death and Autonomic Dysfunction. In J Engel Jr, TA Pedley (eds), Epilepsy: a Comprehensive Textbook. Philadelphia: Lippincott–Raven, 1997;1943–1955.

45. Johnston SC, Siedenberg R, Min J, et al. Central apnea and acute cardiac ischemia in a sheep model of epileptic sudden death. Ann Neurol 1997;42:588–594.

46. Kapoor WN. Diagnostic evaluation of syncope. Am J Med 1991;90:91–94.

47. Aminoff MJ, Schienman MM, Griffin JC, et al. Electrocerebral accompaniments of syncope associated with malignant ventricular arrhythmias. Ann Intern Med 1988;108:791–795.

48. Wijdicks EF, Sharborough FW. New-onset seizures in critically-ill patients. Neurology 1993;43:1042–1044.

49. Zaccara G, Muscas GC, Messori A. Clinical features, pathogenesis, and management of drug-induced seizures. Drug Saf 1990;5:109–151.

50. Keilson GR, Schwaartz WJ, Recht LD. The preponderance of posterior circulatory events is independent of the route of cardiac catheterization. Stroke 1992;23:1358.

51. Galbreath C, Salgado ED, Furlan AJ, Hollman J. Central nervous system complications of percutaneous transluminal angioplasty. Stroke 1986;17:616.

52. Takyanagi K, Hisauchi I, Watanabe J, et al. Carbamazepine-induced sinus node dysfunction and atrioventricular block in elderly women. Jpn Heart J 1998;39:469–479.

53. Steinhoff BJ, Stodiek SR, Tiecks FP, et al. Cardiac side effects and ECG changes with lamotrigine? A clinical study. Schweiz Arch Neurol Psychiatr 1994;145:8–12.

54. Meyer FB, Cascino GD, Whisnant JP, et al. Nimodipine as an add-on therapy for intractable epilepsy. Mayo Clin Proc 1995;70:623–627.

55. Pledger GW, Sackellares JC, Treiman DM, et al. Flunarizine for treatment of partial seizures: results of a concentration-controlled trial. Neurology 1994;44:1830–1836.

56. Evers ML, Izhar A, Aquil A. Cardiac monitoring after phenytoin overdose. Heart Lung 1997;26:325–328.

57. Asconape JJ, Moore DD, Zipes DP, et al. Bradycardia and asystole with the use of vagus nerve stimulation for the treatment of epilepsy: a rare complication of intra-operative device testing. Epilepsia 1999;40:1452–1454.

58. Setty AB, Vaughn BV, Quint SR, et al. Heart period variability during vagal nerve stimulation. Seizure 1998;7:213–217.

59. Best TH, Franz DN, Gilbert DL, et al. Cardiac complications in pediatric patients on the ketogenic diet. Neurology 2000;54:2328–2330.

60. Starc TJ, Bierman FZ, Pavlakis SG, et al. Cardiac size and function during ACTH-induced systolic systemic hypertension in infants. Am J Cardiol 1993;73:57–64.

61. Oppenheimer SM, Gelb A, Girvin JP, et al. Cardiovascular effects of human insular cortex stimulation. Neurology 1992;42:1727–1732.

Adapted from: Boggs J. Cardiac disorders. In: Ettinger AB and Devinsky O, eds. . Managing epilepsy and co-existing disorders. Boston: Butterworth-Heinemann; 2002;39-47.
With permission from Elsevier (www.elsevier.com). 

Reviewed by: Jane Boggs | MD on 6/2004